X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oxaliplatin (306) 306
index medicus (234) 234
oncology (229) 229
chemotherapy (220) 220
humans (220) 220
pancreatic cancer (177) 177
cancer (173) 173
gemcitabine (153) 153
antineoplastic combined chemotherapy protocols - therapeutic use (140) 140
male (137) 137
female (132) 132
pancreatic neoplasms - drug therapy (130) 130
irinotecan (128) 128
middle aged (126) 126
aged (121) 121
metastasis (107) 107
survival (106) 106
adult (90) 90
adenocarcinoma (88) 88
care and treatment (88) 88
pancreatic neoplasms - pathology (86) 86
deoxycytidine - analogs & derivatives (82) 82
treatment outcome (78) 78
5-fluorouracil (75) 75
medicine & public health (75) 75
fluorouracil - administration & dosage (73) 73
folfirinox (72) 72
antineoplastic combined chemotherapy protocols - adverse effects (70) 70
camptothecin - analogs & derivatives (69) 69
colorectal cancer (66) 66
organoplatinum compounds - administration & dosage (66) 66
fluorouracil (65) 65
patients (65) 65
pharmacology & pharmacy (63) 63
therapy (63) 63
clinical trials (62) 62
leucovorin (61) 61
phase-iii trial (61) 61
cancer therapies (60) 60
1st-line treatment (59) 59
leucovorin - administration & dosage (57) 57
research (55) 55
trial (53) 53
adenocarcinoma - drug therapy (52) 52
camptothecin - administration & dosage (52) 52
cancer research (52) 52
folinic acid (52) 52
analysis (50) 50
aged, 80 and over (49) 49
disease-free survival (49) 49
deoxycytidine - administration & dosage (47) 47
surgery (47) 47
survival rate (47) 47
antineoplastic combined chemotherapy protocols - administration & dosage (45) 45
drug therapy (44) 44
metastases (44) 44
neoplasm metastasis (44) 44
pharmacology/toxicology (44) 44
prognosis (43) 43
antineoplastic agents (42) 42
antimitotic agents (41) 41
combination (40) 40
cancer patients (39) 39
tumors (39) 39
deoxycytidine - therapeutic use (38) 38
capecitabine (37) 37
fluorouracil - therapeutic use (37) 37
pancreatic neoplasms - mortality (37) 37
liver neoplasms - secondary (36) 36
colorectal neoplasms - pathology (35) 35
fluorouracil - adverse effects (35) 35
organoplatinum compounds - adverse effects (35) 35
toxicity (35) 35
bevacizumab (34) 34
neoplasm staging (34) 34
retrospective studies (34) 34
colorectal neoplasms - drug therapy (32) 32
cisplatin (31) 31
health aspects (31) 31
antineoplastic agents - therapeutic use (30) 30
organoplatinum compounds - therapeutic use (30) 30
hematology, oncology and palliative medicine (28) 28
leucovorin - adverse effects (28) 28
leucovorin - therapeutic use (28) 28
carcinoma (27) 27
colorectal-cancer (27) 27
gastroenterology & hepatology (27) 27
nab-paclitaxel (27) 27
resection (27) 27
usage (27) 27
cetuximab (26) 26
deoxycytidine - adverse effects (26) 26
liver neoplasms - drug therapy (26) 26
plus gemcitabine (26) 26
studies (26) 26
animals (25) 25
medical prognosis (25) 25
oncology, experimental (25) 25
phase-ii trial (25) 25
2nd-line chemotherapy (24) 24
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2011, Volume 364, Issue 19, pp. 1817 - 1825
In this study, a four-drug combination chemotherapy regimen was associated with objective responses in more than 30% of patients and increased survival by more... 
PHASE-III TRIAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | SOLID TUMORS | CLINICAL-TRIALS | IRINOTECAN | OXALIPLATIN | 1ST-LINE THERAPY | COMBINATION | CARCINOMA | COOPERATIVE-ONCOLOGY-GROUP | Leucovorin - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Camptothecin - analogs & derivatives | Severity of Illness Index | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Quality of Life | Aged | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Chemotherapy, Combination | Usage | Care and treatment | Gemcitabine | Pancreatic cancer | Leucovorin | Comparative analysis | Drug therapy | Fluorouracil | Clinical trials | Cytotoxicity | Pancreas | Patients | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 25, pp. 2395 - 2406
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 10/2015, Volume 22, Issue 11, pp. 3512 - 3521
Journal Article
British Journal of Cancer, ISSN 0007-0920, 09/2015, Volume 113, Issue 7, pp. 989 - 995
Journal Article
Journal Article
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 03/2016, Volume 114, Issue 7, pp. 737 - 743
Journal Article